ImaRx Financial Statements
ImaRx Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
This data is provided as per license from EDGAR Online
ImaRx Income Statement
| 2007 | 2006 | 2005 | |
|---|---|---|---|
| Revenue ($ mil.) | 8.4 | 1.3 | 0.6 |
| Gross Profit ($ mil.) | 4.8 | 1.1 | -- |
| Operating Income ($ mil.) | (8.7) | (15.7) | (31.3) |
| Total Net Income ($ mil.) | (8.8) | (0.7) | (27.9) |
| Diluted EPS (Net Income) | (3.16) | -- | -- |
ImaRx Stock Quote & Chart
09/05/08 13:53:58 EST •
NASDAQ •
0.11
•
 -0.0120
•
-9.8361 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
ImaRx Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 0.19 | 3.51 | 1.54 |
| Price/Earnings Ratio | -- | 15.32 | 15.62 |
| Price/Book Ratio | 0.16 | 2.89 | 1.49 |
| Price/Cash Flow Ratio | 0.83 | 12.48 | 9.59 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed ImaRx Financial Ratios
ImaRx Competitive Intelligence
| Concentric Medical | Edwards Lifesciences | Genentech | |
|---|---|---|---|
| Annual Sales ($ mil.) | 11.3 | 1,091.1 | 11,724.0 |
| Employees | 81 | 5,600 | 11,174 |
| Market Cap ($ mil.) | -- | 3,388.3 | 103,517.0 |
Competitive Landscape
